Session

IBD (Posters)

HUMAN INTESTINAL CD103+SIRP-ALPHA+ CONVENTIONAL DENDRITIC CELLS FROM PATIENTS WITH CROHN´S DISEASE PRIME IL-17+ T-CELLS
HUMAN INTESTINAL CD103+SIRP-ALPHA+ CONVENTIONAL DENDRITIC CELLS FROM PATIENTS WITH CROHN´S DISEASE PRIME IL-17+ T-CELLS

6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY
6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY

TRYPTOPHAN DEGRADATION PRODUCTS AS UNIFYING BIOMARKERS OF SEVERITY AND LONG-TERM DISEASE CONTROL IN CHRONIC INFLAMMATORY DISEASES
TRYPTOPHAN DEGRADATION PRODUCTS AS UNIFYING BIOMARKERS OF SEVERITY AND LONG-TERM DISEASE CONTROL IN CHRONIC INFLAMMATORY DISEASES

NON-INVASIVE ASSESSMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
NON-INVASIVE ASSESSMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

SYSTEMATIC REVIEW AND META-ANALYSIS: MICROSCOPIC COLITIS IS A RISK FACTOR FOR LOW BONE DENSITY
SYSTEMATIC REVIEW AND META-ANALYSIS: MICROSCOPIC COLITIS IS A RISK FACTOR FOR LOW BONE DENSITY

THE BURDEN OF URINARY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS-SECTIONAL OBSERVATIONAL STUDY
THE BURDEN OF URINARY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS-SECTIONAL OBSERVATIONAL STUDY

DELAYED IBD DIAGNOSIS INCREASES RISK OF REQUIRING BIOLOGICS IN FIRST 4-YEARS - AN INCEPTION COHORT STUDY
DELAYED IBD DIAGNOSIS INCREASES RISK OF REQUIRING BIOLOGICS IN FIRST 4-YEARS - AN INCEPTION COHORT STUDY

DELAYED IBD DIAGNOSIS LEADS TO WORSE OUTCOMES OVER YEARS, WITH MULTIPLE IMPLICATIONS ON SERVICE DELIVERY
DELAYED IBD DIAGNOSIS LEADS TO WORSE OUTCOMES OVER YEARS, WITH MULTIPLE IMPLICATIONS ON SERVICE DELIVERY

DISEASE ACTIVITY PATTERNS OF INFLAMMATORY BOWEL DISEASE - A DANISH NATIONWIDE COHORT STUDY 1995-2018
DISEASE ACTIVITY PATTERNS OF INFLAMMATORY BOWEL DISEASE - A DANISH NATIONWIDE COHORT STUDY 1995-2018

POSSIBILITIES FOR DIFFERENTIAL DIAGNOSIS OF NOSOLOGICAL FORMS OF INFLAMMATORY BOWEL DISEASE USING ERYTHROCYTE AND BLOOD SERUM MEMBRANE FATTY ACIDS
POSSIBILITIES FOR DIFFERENTIAL DIAGNOSIS OF NOSOLOGICAL FORMS OF INFLAMMATORY BOWEL DISEASE USING ERYTHROCYTE AND BLOOD SERUM MEMBRANE FATTY ACIDS

BIOLOGICALS AND SMALL MOLECULE COMBOTHERAPIES:PROMISING EXPERIENCE IN REFRACTORY IBD PATIENTS
BIOLOGICALS AND SMALL MOLECULE COMBOTHERAPIES:PROMISING EXPERIENCE IN REFRACTORY IBD PATIENTS

DE NOVO INFLAMMATORY BOWEL DISEASE PICKED UP VIA NATIONAL BOWEL CANCER SCREENING PROGRAMME: 10 YEAR EXPERIENCE AT A LARGE ENGLISH SCREENING CENTRE
DE NOVO INFLAMMATORY BOWEL DISEASE PICKED UP VIA NATIONAL BOWEL CANCER SCREENING PROGRAMME: 10 YEAR EXPERIENCE AT A LARGE ENGLISH SCREENING CENTRE

EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY

ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

INDICATIONS, OUTCOMES AND OTHER ASPECTS RELATED TO THE USE OF THE ENDOSCOPIC CAPSULE IN THE PEDIATRIC AGE
INDICATIONS, OUTCOMES AND OTHER ASPECTS RELATED TO THE USE OF THE ENDOSCOPIC CAPSULE IN THE PEDIATRIC AGE

SARCOPENIA AS A PREDICTIVE MARKER IN INFLAMMATORY BOWEL DISEASE
SARCOPENIA AS A PREDICTIVE MARKER IN INFLAMMATORY BOWEL DISEASE

QUALITY CRITERIA IN SCREENING COLONOSCOPY FOR COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE
QUALITY CRITERIA IN SCREENING COLONOSCOPY FOR COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE

THE IMPACT OF BOWEL URGENCY ON THE LIVES OF PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
THE IMPACT OF BOWEL URGENCY ON THE LIVES OF PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

BOWEL URGENCY COMMUNICATION GAP BETWEEN HEALTH CARE PROFESSIONALS AND PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
BOWEL URGENCY COMMUNICATION GAP BETWEEN HEALTH CARE PROFESSIONALS AND PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EFFECT OF A GLUTEN-FREE DIET ON THE DISEASES SEVERITY, QUALITY OF LIFE, AND INFLAMMATORY MARKERS AMONG PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: A TRIPLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
EFFECT OF A GLUTEN-FREE DIET ON THE DISEASES SEVERITY, QUALITY OF LIFE, AND INFLAMMATORY MARKERS AMONG PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: A TRIPLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL

Item 221 - 240 / 612
1 2 3 4 5 6 7 8 9 10 11
12
13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31